Egyptian International Pharmaceutical Industries Company (EGX:PHAR)
Egypt
· Delayed Price · Currency is EGP 52.30
+0.27 (0.52%)
At close: Aug 14, 2025
EGX:PHAR Cash Flow Statement
Financials in millions EGP. Fiscal year is January - December.
Millions EGP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 1,602 | 1,532 | 1,083 | 804.74 | 654.17 | 576.28 | Upgrade
|
| Depreciation & Amortization | 102.82 | 98.89 | 105.25 | 99.26 | 90.88 | 139.57 | Upgrade
|
| Other Amortization | 3.77 | 3.92 | - | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Assets | -1.27 | -0.22 | -4.69 | -3.7 | -2.78 | -3.8 | Upgrade
|
| Loss (Gain) From Sale of Investments | -221.22 | -24.73 | -55.66 | -25.51 | - | - | Upgrade
|
| Loss (Gain) on Equity Investments | - | - | - | - | -43.37 | -37.18 | Upgrade
|
| Provision & Write-off of Bad Debts | 565 | 580 | 36.78 | 30.34 | - | - | Upgrade
|
| Other Operating Activities | -767.95 | -1,038 | -236.74 | -268.36 | -53.83 | -226.42 | Upgrade
|
| Change in Accounts Receivable | -740.44 | -1,125 | -613.4 | -567.8 | - | 106.5 | Upgrade
|
| Change in Inventory | -728.52 | -1,359 | -84.58 | -392.29 | -234.77 | -359.03 | Upgrade
|
| Change in Accounts Payable | 7.37 | 57.32 | -137.74 | 26.5 | -26.49 | -31.05 | Upgrade
|
| Operating Cash Flow | -177.99 | -1,274 | 92.48 | -296.81 | 383.82 | 164.86 | Upgrade
|
| Operating Cash Flow Growth | - | - | - | - | 132.81% | -41.18% | Upgrade
|
| Capital Expenditures | -1,652 | -2,846 | -2,290 | -562.95 | -437.09 | -203.56 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.07 | 0.5 | 5.2 | 3.75 | 2.85 | 4.13 | Upgrade
|
| Investment in Securities | -327.6 | -29.7 | -84 | - | - | -79.77 | Upgrade
|
| Other Investing Activities | 220.96 | 196.41 | 39.35 | 29.41 | 62.88 | 72.75 | Upgrade
|
| Investing Cash Flow | -1,758 | -2,679 | -2,330 | -529.8 | -371.36 | -206.46 | Upgrade
|
| Short-Term Debt Issued | - | 2,340 | 3.54 | 813.48 | - | - | Upgrade
|
| Long-Term Debt Issued | - | 1,950 | 2,097 | 455.98 | 279.64 | 789.87 | Upgrade
|
| Total Debt Issued | 1,195 | 4,290 | 2,100 | 1,269 | 279.64 | 789.87 | Upgrade
|
| Long-Term Debt Repaid | - | -2.4 | -78.64 | -172.92 | -310.85 | - | Upgrade
|
| Net Debt Issued (Repaid) | 1,129 | 4,288 | 2,022 | 1,097 | -31.22 | 789.87 | Upgrade
|
| Issuance of Common Stock | 1,501 | - | 495.85 | - | - | - | Upgrade
|
| Repurchase of Common Stock | - | - | - | - | -12.58 | -89.86 | Upgrade
|
| Common Dividends Paid | -542.11 | -434.01 | -309.76 | -393.14 | -383.57 | -503.1 | Upgrade
|
| Financing Cash Flow | 2,088 | 3,854 | 2,208 | 703.41 | -427.37 | 196.91 | Upgrade
|
| Foreign Exchange Rate Adjustments | 210.53 | 719.49 | 222.29 | 294.58 | -6.25 | -11.55 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | 0 | - | - | - | Upgrade
|
| Net Cash Flow | 361.7 | 619.59 | 192.83 | 171.38 | -421.17 | 143.77 | Upgrade
|
| Free Cash Flow | -1,830 | -4,121 | -2,198 | -859.77 | -53.27 | -38.7 | Upgrade
|
| Free Cash Flow Margin | -20.75% | -54.29% | -42.01% | -21.74% | -1.56% | -1.34% | Upgrade
|
| Free Cash Flow Per Share | - | -27.70 | -14.77 | -8.67 | -0.54 | -0.40 | Upgrade
|
| Cash Interest Paid | 571.17 | 922.95 | 388.52 | 195.42 | - | 83.16 | Upgrade
|
| Cash Income Tax Paid | 58.53 | 87.8 | 89.36 | 59.92 | 136.25 | 107.69 | Upgrade
|
| Levered Free Cash Flow | -1,373 | -3,701 | -2,248 | -862.05 | -148.76 | -131.13 | Upgrade
|
| Unlevered Free Cash Flow | -590.84 | -3,120 | -2,005 | -739.91 | -63.61 | -79.15 | Upgrade
|
| Change in Working Capital | -1,462 | -2,427 | -835.72 | -933.58 | -261.25 | -283.59 | Upgrade
|
Updated Mar 2, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.